- This is the first time the plasma industry has partnered with a government in a groundbreaking global public-private alliance to achieve plasma medicine self-sufficiency, a game-changing model that ...

Plasma donation is a painless procedure that thousands of people do each day. It is a great way to take a break in the middle of the day while helping others! All donors receive a thorough health ...

- The operation aligns with Grifols' commitment to helping countries reach self-sufficiency of life-sustaining plasma-derived medicines According to Víctor Grífols Deu, co-CEO of Grifols, "This deal ...

- The combination of Grifols and Talecris will create a diversified, global provider of life-saving and life enhancing plasma protein therapeutics built on the strong global presence of Grifols and ...

Plasma is the lifeblood of Grifols, serving as the raw material for the biological medicines that generate most of the company’s revenue. But the Barcelona-based firm has eyed expansion beyond ...

CHAPEL HILL — Americans who have recovered from COVID-19 may help save others from the disease by donating their convalescent plasma at the University of North Carolina in Chapel Hill, or at plasma ...

The addition of the Clayton site in 2011 marked a new milestone for Grifols (GRFS), turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The ...

Market share in the global plasma-derived protein business is concentrated among a small number of global players. Grifols lifted itself to the level of competitors Takeda and CSL with the $3.7 ...

Market share in the global plasma-derived protein business is concentrated among a small number of global players, and Grifols lifted itself to the level of competitors Takeda and CSL with the $3.7 ...

Revenue momentum remains strong and EBITDA execution is intact, but FX-adjusted guidance implies Q4 slightly below consensus ...

LONDON (Reuters) - Shares in Grifols fell as much as over 40% on Tuesday, wiping $3.83 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the ...

BARCELONA, Spain, April 18, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today officially ...